StemWave Patents List
In accordance with Section 287(a) of Title 35 of the United States Code, StemWave products are associated with the following patents:
US7,841,995
US8,535,249
Intended Use Modus-F by StemWave: The Modus-F by StemWave, utilizing Cellular Response Technology, is intended for use in addressing minor aches and pains in accordance with the User Manual (IFU). Use of the product for any other purpose has not been reviewed by the U.S. Food and Drug Administration and is considered off-label use. Please consult the User Manual (IFU) and all labeling provided with the product prior to use.
StemWave
Stories
Company
Support
Individual results may vary. Neither StemWave nor any of its subsidiaries dispense medical advice. The contents of this website do not constitute medical, legal, or any other type of professional advice. Information related to various health, medical, and fitness conditions and their treatment is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.